China Meheco Group Co., Ltd. (SHSE:600056) agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million on December 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.86 CNY | +0.09% | -0.09% | -2.78% |
May. 15 | China Meheco Group Chairman, Vice Chairman Resign | MT |
Apr. 29 | China Meheco Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-2.78% | 2.24B | |
-1.52% | 24.18B | |
+5.62% | 8.46B | |
+8.55% | 8.34B | |
-23.71% | 7.64B | |
+15.20% | 5.33B | |
+2.68% | 4.12B | |
-6.90% | 3.92B | |
+5.56% | 3.89B | |
+18.80% | 3.54B |
- Stock Market
- Equities
- 600056 Stock
- News China Meheco Group Co., Ltd.
- China Meheco Group Co., Ltd. agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million.